NCT05967949View on ClinicalTrials.gov

A Retrospective Clinical Study on the First-line Maintenance Treatment of PTCL With Chidamide.

RecruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

April 1, 2023

Primary Completion Date

April 1, 2026

Study Completion Date

April 1, 2028

Conditions
PTCL
Interventions
DRUG

chidamide

This subset of patients received chidamide as first-line maintenance therapy.

Trial Locations (1)

210029

RECRUITING

Hematological Department, People's Hospital of Jiangsu Province, Nanjing

All Listed Sponsors
lead

The First Affiliated Hospital with Nanjing Medical University

OTHER